| Tereza Martinu, MD | |
|
300 W 27th St, Lumberton, NC 28358-3075 | |
| (910) 671-5000 | |
| Not Available |
| Full Name | Tereza Martinu |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 300 W 27th St, Lumberton, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295847416 | NPI | - | NPPES |
| 5905119 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 200500527 (North Carolina) | Primary |
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
The scientists observed that a protein called P-glycoprotein (P-gp), which causes resistance to chemotherapy in many tumor types, is able to physically "jump" or transfer between tumor cells and retain its functional properties, protecting otherwise sensitive cells from the effects of anti-cancer treatment in vivo and in vitro.
Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic areas covering sealants and orthobiologics, announced today that it has closed a financing round of CHF15M. An additional investment is expected in a second closing later this year.
Researchers from the University of Southern Denmark have identified how a mutated protein can lead to holes in a protein sitting in a cell's membrane. Such holes cause high blood pressure, and the discovery can now lead to new and better medication for high blood pressure.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
A flawed system at the Jacobi Medical Center in New York, which meant that hundreds of women were not informed of the results of their cancer screening tests has resulted in the firing of its executive director just a week after the slip up was discovered.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tereza Martinu, MD 106 Research Drive, Bldg Hsrb - 2, Ste 2073, Po Box Dumc 103000, Durham, NC 27710 Ph: (919) 668-7762 | Tereza Martinu, MD 300 W 27th St, Lumberton, NC 28358-3075 Ph: (910) 671-5000 |
News Archive
The scientists observed that a protein called P-glycoprotein (P-gp), which causes resistance to chemotherapy in many tumor types, is able to physically "jump" or transfer between tumor cells and retain its functional properties, protecting otherwise sensitive cells from the effects of anti-cancer treatment in vivo and in vitro.
Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic areas covering sealants and orthobiologics, announced today that it has closed a financing round of CHF15M. An additional investment is expected in a second closing later this year.
Researchers from the University of Southern Denmark have identified how a mutated protein can lead to holes in a protein sitting in a cell's membrane. Such holes cause high blood pressure, and the discovery can now lead to new and better medication for high blood pressure.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
A flawed system at the Jacobi Medical Center in New York, which meant that hundreds of women were not informed of the results of their cancer screening tests has resulted in the firing of its executive director just a week after the slip up was discovered.
› Verified 5 days ago
Charles R. Beasley, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 395 W 27th St, Lumberton, NC 28358 Phone: 910-739-7551 Fax: 910-738-3764 | |
Dr. Christopher Ronald Walters, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 403 W 27th St, Lumberton, NC 28358 Phone: 910-671-6619 | |
Paul Sierszulski, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 395 W 27th St, Lumberton, NC 28358 Phone: 910-739-7557 Fax: 910-739-2332 | |
Nam Huynh, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 395 W 27th St, Lumberton, NC 28358 Phone: 910-739-7551 Fax: 910-739-2332 | |
Sadanand Belinje Hegde, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 725 Oakridge Blvd Ste A3, Lumberton, NC 28358 Phone: 910-738-1141 Fax: 910-738-6011 | |
Joshua Ruiz, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 West 27th Street, Southeastern Health, Lumberton, NC 28359 Phone: 910-272-1478 Fax: 910-671-5392 | |
Susan Marie Pereira, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-735-8781 |